Buy PeptidesReference compendium

About / Peptides / GHRP-2

Sport and recovery

GHRP-2

Chemical compound

  • FormulaC45H55N9O6
  • Molecular weight818.0 g/mol
  • CAS number158861-67-7
  • PubMed results212

Reference sheet 14 of 40Data retrieved 2026-10-08.PubChem · PubMed · Wikipedia

Available in the shop

See the whole catalogue →

Sold for in vitro laboratory research only — not for human or animal consumption. ≥99% purity specification.

Identification

Field of researchSport and recovery
PubChem namePralmorelin
FormulaC45H55N9O6
Molecular weight818.0 g/mol
CAS number158861-67-7
Also known asKP-102, pralmorelina, pralmoreline, E6S6E1F19M, KP 102, Ala-beta-Nal-Ala-Trp-Phe-Lys-NH2, D-ALA-3-(2-NAPHTHYL)-D-ALA-ALA-TRP-D-PHE-LYS-NH2, pralmorelinum, RefChem:175716, Pralmorelin (free base)
PubChemCID 6918245

Summary

Pralmorelin is a growth hormone secretagogue (GHS) used as a diagnostic agent that is marketed by Kaken Pharmaceutical in Japan in a single-dose formulation for the assessment of growth hormone deficiency (GHD).

From Wikipedia, available under CC BY-SA 4.0. Short description from Wikidata (CC0).

Published research

Titles are shown as published. Listing a paper is not an endorsement of its findings, and many papers on research peptides are laboratory or animal studies: the type of study is shown when PubMed records it.

  1. Ipamorelin, the first selective growth hormone secretagogueRaun K, Hansen BS, Johansen NL et al. · Eur J Endocrinol, 1998 · PMID 9849822 · DOI
  2. Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LNReviewDrugs R D, 2004 · PMID 15230633 · DOI
  3. Growth hormone-releasing peptidesResearch Support, Non-U.S. Gov'tReviewGhigo E, Arvat E, Muccioli G et al. · Eur J Endocrinol, 1997 · PMID 9186261 · DOI
  4. Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometryEvaluation StudyResearch Support, Non-U.S. Gov'tOkano M, Sato M, Ikekita A et al. · Rapid Commun Mass Spectrom, 2010 · PMID 20552695 · DOI
  5. Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptideDoi N, Hirotani C, Ukai K et al. · Arzneimittelforschung, 2004 · PMID 15646370 · DOI
  6. Gateways to clinical trialsReviewBayes M, Rabasseda X, Prous JR · Methods Find Exp Clin Pharmacol, 2002 · PMID 12092009
  7. Physiologically based pharmacokinetic model for pralmorelin hydrochloride in ratsNasu R, Kumagai Y, Kogetsu H et al. · Drug Metab Dispos, 2005 · PMID 16033952 · DOI
  8. Adult growth hormone deficiency: current conceptsResearch Support, Non-U.S. Gov'tReviewFukuda I, Hizuka N, Muraoka T et al. · Neurol Med Chir (Tokyo), 2014 · PMID 25070016 · DOI

Top 8 of 212 results, by relevance. See all on PubMed.

Search query "GHRP-2"[Title/Abstract] OR "pralmorelin"[Title/Abstract]

Data provenance

DataSourceRecord
Chemical identity and structurePubChemCID 6918245
Published literaturePubMedSearch on PubMed
Summary sentenceWikipediaPralmorelin

Data retrieved 2026-10-08. See About for the sources. How the data is collected and checked: Methods.